Literature DB >> 16966268

IgM multiple myeloma: report of four cases and review of the literature.

Ombretta Annibali1, Maria Teresa Petrucci, Patrizia Del Bianco, Cristiano Gallucci, Anna Levi, Robin Foà, Giuseppe Avvisati.   

Abstract

The differential diagnosis between multiple myeloma (MM) and Waldenström's macroglobulinemia (WM) is generally well defined. Consistent with a diagnosis of MM is the presence of a non-IgM monoclonal gammopathy associated to multiple osteolytic lesions and plasma cell infiltration of the bone marrow. Characteristic of WM is the presence of an IgM monoclonal gammopathy associated to lymphoadenopathy, hepatosplenomegaly, anemia and hyperviscosity syndrome in the presence of a monoclonal lymphoplasmacytoid proliferation in the bone marrow. Nonetheless, few cases of IgM myeloma have been reported that display clinico-pathologic features intermediate between MM and WM. Here, this study describes four of 317 (1.2%) patients with an IgM monoclonal gammopathy in whom the morphologic and clinical features were consistent with a diagnosis of IgM myeloma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16966268     DOI: 10.1080/10428190600604450

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  8 in total

1.  IgM multiple myeloma presenting with bleeding tendency: a case report with immunophenotype analysis.

Authors:  Ling Zheng; Zhiyong Zeng; Junfang Lin; Junmin Chen
Journal:  Oncol Lett       Date:  2010-11-23       Impact factor: 2.967

2.  Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study.

Authors:  Donna E Reece; David H Vesole; Smriti Shrestha; Mei-Jie Zhang; Waleska S Pérez; Angela Dispenzieri; Gustavo A Milone; Muneer Abidi; Harold Atkins; Asad Bashey; Christopher N Bredeson; Willem Bujan Boza; César O Freytes; Robert Peter Gale; James L Gajewski; John Gibson; Gregory A Hale; Shaji Kumar; Robert A Kyle; Hillard M Lazarus; Philip L McCarthy; Santiago Pavlovsky; Vivek Roy; Daniel J Weisdorf; Peter H Wiernik; Parameswaran N Hari
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2010-12

3.  IgM multiple myeloma with an extremely rare non-aggressive presentation: A case report.

Authors:  Thomas Greuter; Martin Browne; Corina Dommann-Scherrer; Daniel Binder; Christoph Renner; Ursula Kapp
Journal:  Oncol Lett       Date:  2016-08-17       Impact factor: 2.967

4.  IgM multiple myeloma: a diagnostic challenge in a patient with coexisting chronic lymphocytic leukaemia.

Authors:  Saman Hewamana; Chris Pepper; Steve Couzens; Alun Thomas; Steven Knapper
Journal:  Int J Hematol       Date:  2008-10-11       Impact factor: 2.490

5.  Efficacy and outcome of autologous transplantation in rare myelomas.

Authors:  Curly Morris; Mary Drake; Jane Apperley; Simona Iacobelli; Anja van Biezen; Bo Bjorkstrand; Hartmut Goldschmidt; Jean-Luc Harousseau; Gareth Morgan; Theo de Witte; Dietger Niederwieser; Gosta Gahrton
Journal:  Haematologica       Date:  2010-10-22       Impact factor: 9.941

6.  Serum Free Light Chain Only Myeloma with Cytoplasmic IgM.

Authors:  Hideaki Ebana; Ken-Ichi Nakamura; Yoshihiro Nozawa; Ritsuko Seki; Masayuki Mita
Journal:  Case Rep Hematol       Date:  2014-06-17

7.  IgM multiple myeloma presenting with spinal cord compression caused by a plasmacytoma: A case report.

Authors:  Ihssan Tahan; Jim Seale; David Edwards
Journal:  Cases J       Date:  2008-10-02

Review 8.  Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse models.

Authors:  Siegfried Janz
Journal:  ISRN Hematol       Date:  2013-09-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.